Delegation of the European Union to Japan

Lecture by the President of AMED at the EU Delegation to Japan

27/04/2020 - 07:44

On 27 March, Dr. Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED), who is also a key person in the G-7 discussions on research and development actions addressing the COVID-19 outbreak, visited the EU Delegation to Japan to inform EU and its Science and Technology Counsellors about their role in addressing the COVID-19 outbreak and exchanged views on collaboration opportunities.

During his lecture, Dr. Suematsu informed that a  large part of AMED's 2020 supplementary budget, approximately 160 million euro, is likely to be dedicated to research actions addressing COVID-19, possibly jointly with international partners. He highly praised collaboration with the EU under the International ECMO Network (ECMONet), as well as GLoPID-R and EDCTP, and showed interest in exploring further opportunities, such as research on CureVac.

PDF icon Presentation slide "How to tackle COVID-19 in AMED.pdf



EU Delegation to Japan
Europa house, 4-6-28, Minami-Azabu, Minato-ku

106-0047 Tokyo